VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 106 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,606,957 | -37.9% | 104,756 | -3.7% | 0.74% | -37.2% |
| Q2 2023 | $2,587,519 | +7.2% | 108,765 | +14.6% | 1.18% | -39.8% |
| Q1 2023 | $2,414,485 | -17.3% | 94,909 | -5.1% | 1.97% | +13.4% |
| Q4 2022 | $2,920,474 | +39.1% | 99,982 | -2.3% | 1.73% | +44.6% |
| Q3 2022 | $2,100,000 | +303.1% | 102,372 | +127.3% | 1.20% | +280.6% |
| Q2 2022 | $521,000 | -42.6% | 45,039 | -8.2% | 0.32% | -45.4% |
| Q1 2022 | $907,000 | – | 49,065 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,696,340 | $55,302,000 | 8.89% |
| TCG Crossover Management, LLC | 1,164,000 | $23,874,000 | 7.16% |
| VR Adviser, LLC | 2,130,308 | $43,693,000 | 6.74% |
| Fairmount Funds Management LLC | 1,369,623 | $28,091,000 | 4.94% |
| Paradigm Biocapital Advisors LP | 1,636,211 | $33,559,000 | 4.47% |
| Kynam Capital Management, LP | 1,000,000 | $20,510,000 | 4.32% |
| Vivo Capital, LLC | 1,660,019 | $34,047,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 362,735 | $7,440,000 | 3.20% |
| Ghost Tree Capital, LLC | 535,000 | $10,973,000 | 3.08% |
| Logos Global Management LP | 1,000,000 | $20,510,000 | 2.52% |